Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
Study NCT ID:
NCT01025505
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2009-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-01
First Submit QC Date:
None
Study First Post Date:
2009-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-10
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL